NCT07601191

Brief Summary

The goal of this clinical trial is to validate the clinical application capabilities of AutoFUSE. The main questions it aims to answer are: Does AutoFUSE reduce the time required to obtain standard planes in first-trimester ultrasound scan? Does AutoFUSE improve the accuracy of standard plane acquisition in first-trimester ultrasound scan? What safety outcomes occur in participants undergoing AutoFUSE-assisted ultrasound examination? Researchers will compare AutoFUSE-assisted ultrasound scan with standard clinical protocol (SCP) ultrasound scan to evaluate the efficacy and safety of AutoFUSE in clinical practice. Participants will: Undergo either AutoFUSE-assisted ultrasound scan or standard clinical ultrasound scan according to the study design. Complete scheduled visits for examinations, data collection and follow-up. Provide information related to scan time, image quality and safety during the study.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
10 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

5 months

First QC Date

May 10, 2026

Last Update Submit

May 20, 2026

Conditions

Keywords

First-trimester ultrasoundArtificial intelligenceStandard planeImage quality controlRandomized clinical trial

Outcome Measures

Primary Outcomes (1)

  • The efficiency of standard plane acquisition

    The primary outcome was measured by the time required to obtain the prespecified standard planes during the ultrasound examination.

    Day 1

Secondary Outcomes (1)

  • The accuracy of standard plane acquisition

    Through study completion, an average of 6 months

Study Arms (2)

AutoFUSE-assisted ultrasound scan

EXPERIMENTAL

AutoFUSE-assisted ultrasound scanning throughout the examination.

Diagnostic Test: AutoFUSE system

Traditional ultrasound scan

ACTIVE COMPARATOR

Standard ultrasound scanning according to the standard clinical protocol.

Diagnostic Test: Traditional ultrasound scan

Interventions

AutoFUSE systemDIAGNOSTIC_TEST

AutoFUSE is an AI-based intelligent image quality control system independently developed for first-trimester fetal ultrasound scan (FTFUS).

AutoFUSE-assisted ultrasound scan

Traditional ultrasound scan means the standard clinical ultrasound examination performed by sonographers using routine manual operation to acquire predefined standard anatomical planes, without real-time AI assistance, automatic plane recognition, or automatic image quality assessment. All plane acquisition and quality evaluation are completed manually by the operator.

Traditional ultrasound scan

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • ① Pregnant women undergoing fetal ultrasound examination.
  • ② A singleton pregnancy with a live fetus between 11 and 13+6 weeks with complete outcomes.

You may not qualify if:

  • Incomplete pregnancy outcome information.
  • Unexplained miscarriages. ③ Fetal death.
  • Pregnancies with significant maternal complications.
  • Multiple pregnancies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Wuhan Union Hospital

Wuhan, Hubei, 430022, China

Location

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, 430022, China

Location

Renmin Hospital of Wuhan University

Wuhan, Hubei, 430060, China

Location

MeSH Terms

Conditions

Fetal Diseases

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2026

First Posted

May 22, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations